Unique ID issued by UMIN | UMIN000003042 |
---|---|
Receipt number | R000003689 |
Scientific Title | An exploratory study of administration of cidofovir for adenovirus infection after hematopoietic stem cell transplantation. |
Date of disclosure of the study information | 2010/01/20 |
Last modified on | 2018/07/23 14:41:28 |
An exploratory study of administration of cidofovir for adenovirus infection after hematopoietic stem cell transplantation.
Cidofovir for ADV infection after HSCT
An exploratory study of administration of cidofovir for adenovirus infection after hematopoietic stem cell transplantation.
Cidofovir for ADV infection after HSCT
Japan |
Adenovirus infection after hematopoietic stem cell transplantation.
Hematology and clinical oncology |
Others
NO
Evaluation of efficacy and safety of cidofovir for adenovirus infection after hematopoietic stem cell transplantation.
Safety,Efficacy
Changes in viral load at the end of treatment.
Changes in the symptoms of viral infection at the end of treatment.
Survival at two months after the end of treatment.
Re-administration of antiviral drugs within 2 months after the end of treatment.
Adverse event.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
Intravenous administration of cidofovir, 1mg/kg three times a week for three weeks.
16 | years-old | <= |
Not applicable |
Male and Female
1. Patients who have received hematopoietic stem cell transplantation.
2. Patients with adenovirus infection.
1. Allergy to cidofovir.
2. The serum creatinine is greater than 1.5 mg/dL, the creatinine clearance is equal to or less than 55 mL/min, or the urine protein is greater than 100 mg/dL. 3. HIV-positive patients.
4. A woman during pregnancy or potential pregnancy.
5. Patients who are recognized as inadaptable for this trial.
5
1st name | |
Middle name | |
Last name | Akira Honda |
Univesity of Tokyo Hospital
Hematology and Oncology
7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan
03-3815-5411
ahonda-spr@umin.org
1st name | |
Middle name | |
Last name | Akira Honda |
University of Tokyo Hospital
Hematology and Oncology
7-3-1, Hongo, Bunkyo-ku, Tokyo
03-3815-5411
ahonda-spr@umin.org
Univesity of Tokyo Hospital,
Department of Hematology and Oncology
None
Self funding
NO
2010 | Year | 01 | Month | 20 | Day |
Unpublished
Completed
2009 | Year | 09 | Month | 30 | Day |
2010 | Year | 02 | Month | 01 | Day |
2018 | Year | 07 | Month | 23 | Day |
2018 | Year | 07 | Month | 23 | Day |
2018 | Year | 07 | Month | 23 | Day |
2018 | Year | 07 | Month | 23 | Day |
2010 | Year | 01 | Month | 15 | Day |
2018 | Year | 07 | Month | 23 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003689
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |